# Safety and Pharmacokinetics of KBPA-101 in Hospital Acquired Pneumonia Caused by O11 Pseudomonas Aeruginosa

> **NCT00851435** · PHASE1,PHASE2 · COMPLETED · sponsor: **Kenta Biotech Ltd** · enrollment: 15 (estimated)

## Conditions studied

- Pneumonia
- Ventilator Associated Pneumonia

## Interventions

- **BIOLOGICAL:** KBPA-101

## Key facts

- **NCT ID:** NCT00851435
- **Lead sponsor:** Kenta Biotech Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2009-07
- **Final completion:** 2009-07
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2009-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00851435

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00851435, "Safety and Pharmacokinetics of KBPA-101 in Hospital Acquired Pneumonia Caused by O11 Pseudomonas Aeruginosa". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00851435. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*